THEY DON'T HAVE TO DIE Car accidents. Battlefield injuries. Slips. Falls.

Millions suffer from major blood loss every year. Sadly, more than half die within minutes.

We could save lives

5 million

Deaths from accidental and non-accidental trauma every year

60,000

5 million

Americans who die from hemorrhaging, or blood loss, every year Americans who die from blood loss, every year

50%

5 million

50%

Number of people with traumatic injuries who die within minutes

#1

5 million

50%

Trauma is the leading cause of death for the general public under age 45 Trauma is the leading cause of death for people under 45

The Applications Are Countless

Paramedics

Organ Transplant/Surgery

Paramedics

Military

Organ Transplant/Surgery

Paramedics

Ambulance

Organ Transplant/Surgery

The solution is here

We believe we have found a way to keep trauma patients alive—not just for the first few minutes of trauma, but for up to 6 hours, ensuring sufficient time for them to be transported to a hospital or care setting so they may receive definitive trauma care.

We synthesized a groundbreaking therapy—an estrogen-based, single-dose, small-volume injection—that can be administered during the first hour of trauma at the site of the accident to reduce mortality by more than half in preclinical data.

Preclinical testing was highly supportive of the main objective survival of major blood loss and mitigation of traumatic brain injury, prompting the FDA to approve our drug for human testing.

About

Irshad H. Chaudry received a BSc as well as MSc with honors from Sind University, and a PhD from Monash University, Australia. After his postdoctoral training at University of Toronto, in Canada, he was an appointed as an Instructor and subsequently as an Assistant Professor at the Jewish Hospital and Washington University School of Medicine. He then moved to Yale University as an Associate Professor and subsequently became a Professor. He moved to Michigan State University in 1986 as Professor and Director of Research and in 1996 became the Director of the Center for Surgical Research at Brown University. In 2000, he became the Director of the Center for Surgical Research at the University of Alabama at Birmingham. Upon leaving UAB in 2020, Dr. Chaudry was named Professor Emeritus. He is currently focused on his consulting work and continues to lead, train, and teach at home and abroad. He has over 650 publications to his credit and was a recipient of the NIH MERIT award.

Get Involved

To learn more about our estrogen-based therapy, or to find out how your organization can help bring it to the bedside, please contact The Chaudry Group at ichaudry@thechaudrygroup.com

THEY DON'T HAVE TO DIE Car accidents. Battlefield injuries. Slips. Falls.

We could save lives

5 million

5 million

5 million

60,000

5 million

5 million

50%

5 million

50%

#1

5 million

50%

The Applications Are Countless

Paramedics

Organ Transplant/Surgery

Paramedics

Military

Organ Transplant/Surgery

Paramedics

Ambulance

Organ Transplant/Surgery

Organ Transplant/Surgery

Organ Transplant/Surgery

Organ Transplant/Surgery

Organ Transplant/Surgery

The solution is here

We believe we have found a way to keep trauma patients alive—not just for the first few minutes of trauma, but for up to 6 hours, ensuring sufficient time for them to be transported to a hospital or care setting so they may receive definitive trauma care.

We synthesized a groundbreaking therapy—an estrogen-based, single-dose, small-volume injection—that can be administered during the first hour of trauma at the site of the accident to reduce mortality by more than half in preclinical data.

Preclinical testing was highly supportive of the main objective survival of major blood loss and mitigation of traumatic brain injury, prompting the FDA to approve our drug for human testing.

About

Get Involved

Contact The Chaudry Group